Two Indian Nationals Indicted in US for Counterfeit Ozempic Smuggling Scheme
Two Indian nationals, Swapnadip Roy and Vicky Ramancha, have been indicted by a US federal grand jury for allegedly smuggling and selling counterfeit Ozempic, a diabetes and weight-loss drug, in the United States. The counterfeit products, sourced from China, included fake packaging and inserts to mimic genuine Ozempic. The scheme operated from July 2023 to April 2024 and continued despite FDA seizures and warnings. Roy was extradited from Italy and pleaded not guilty, while Ramancha remains at large. Both face up to 71 years in prison if convicted.
First-hand measurement across 10 sources
We measured how 10 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is negative (39/100). Lens Score 52/100.
Outlets measured: firstpost, ndtv, hindustantimes, moneycontrol, indiatoday, news18, thehindu, economictimes, and 2 more. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (28–45/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 29 Sept, 10:36 pm. Other outlets followed.